Systemic | Jotup

New Generation of AI Platforms Set to Revolutionize the $200 Billion HR Technology Market, Says Josh Bersin Company

Retrieved on:

화요일, 5월 7, 2024

Intelligence, Digital, L&D, AI, HR, Work, Research, Coca-Cola Europacific Partners, HCM, Employment, Organization, Research report, Acquisition, Emergence, Big data, Data management, Architecture, Systemic

AI-powered talent intelligence platforms, which model people around skills, are now becoming the new architecture for the entire HR technology market.

Key Points:

AI-powered talent intelligence platforms, which model people around skills, are now becoming the new architecture for the entire HR technology market.
According to The Josh Bersin Company's latest research study, The Emergence of Enterprise Talent Intelligence: Applying Skills Technology and AI at Work , this pivotal shift signifies an evolution from Talent Intelligence to a comprehensive Enterprise-wide Talent Intelligence.
The Josh Bersin Company sees AI- and data-enriched Talent Intelligence to tackle on-going HR and transformation challenges, such as:
Identifying, assessing, and developing a new generation of leaders.
Josh Bersin, global industry analyst and CEO of The Josh Bersin Company, says:
"Talent Intelligence has grown up, and it now threatens many of the incumbent HR technology vendors.

New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion

Retrieved on:

화요일, 4월 16, 2024

Duke University Hospital, American Heart Journal, American College, Congestion, Research, Baptist Memorial Hospital, Proxy, Heart failure, Pressure, Patient, BVA, Volume analysis, Letter, HF, Systemic, Medical imaging

Oak Ridge, TN, April 16, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces two new studies validating the clinical benefits of blood volume analysis (BVA) as a more precise measurement of congestion in ambulatory heart failure (HF) patients. Data from both studies demonstrated a lack of correlation between surrogate measures and actual blood volume, highlighting the necessity for accurate volume measurement, as provided by BVA.

Key Points:

Data Presented at the American College of Cardiology Scientific Sessions;
Oak Ridge, TN, April 16, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces two new studies validating the clinical benefits of blood volume analysis (BVA) as a more precise measurement of congestion in ambulatory heart failure (HF) patients.
Data from both studies demonstrated a lack of correlation between surrogate measures and actual blood volume, highlighting the necessity for accurate volume measurement, as provided by BVA.
“These studies add to the numerous research papers and trials reporting the value of BVA at measuring congestion to improve outcomes,” stated Jonathan Feldschuh, Daxor’s Chief Scientific Officer.
A research letter published in the American Heart Journal, titled, ‘Prognostic Implications of Volume Status Assessed by Blood Volume Analysis in Ambulatory Heart Failure,’ was authored by leading heart failure experts from Duke University Medical Center, Baptist Memorial Hospital and Banner University Medical Center.

Primacorp Ventures Inc. Donates $50,000 to the Canadian Council for Refugees

Retrieved on:

목요일, 3월 21, 2024

Employment, Systemic, Organization, CDI College, Conference, CDI, Education, Reeves College, Miller, Art, Private sector, CCR, Council, Housing, Citizenship, Public sector, Vancouver Career College, Government

Calgary, Alberta, March 21, 2024 (GLOBE NEWSWIRE) -- Primacorp Ventures presented the Canadian Council for Refugees (CCR) with $50,000 on Thursday, November 16.

Key Points:

Calgary, Alberta, March 21, 2024 (GLOBE NEWSWIRE) -- Primacorp Ventures presented the Canadian Council for Refugees (CCR) with $50,000 on Thursday, November 16.
With this donation, Primacorp Ventures is committed to sponsoring the upcoming conferences for the next three years.
Raie announced our commitment to support newcomers through various scholarship programs with CDI College and other colleges; Primacorp Ventures has greatly supported refugees and immigrants .
Together with its business divisions in real estate and healthcare, Primacorp Ventures focuses on changing lives through education, service, and care.

Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)

Retrieved on:

화요일, 4월 2, 2024

The U.S. FDA's approval of LIKMEZ highlighted Appili’s capacity to identify and develop significant opportunities within the infectious disease domain.

Key Points:

The U.S. FDA's approval of LIKMEZ highlighted Appili’s capacity to identify and develop significant opportunities within the infectious disease domain.
Appili licensed the manufacturing and commercialization rights in the U.S. and other selected territories to Saptalis Pharmaceuticals, LLC (“Saptalis”).
Appili, in collaboration with Saptalis, continued the product's development, ultimately achieving FDA approval in the United States.
With FDA approval, future revenue is expected to be derived from milestone payments and royalties from Saptalis under the license agreement.

Martinrea International Inc. Publishes 2023 Sustainability Report

Retrieved on:

금요일, 3월 1, 2024

TSX, Culture, Plant, ESG, Propulsion, Systemic, Carbon, Diversity, CDP, Health, Climate change, Safety, Inclusion, MRE, Creativity, Electricity, Waste management, Renewable energy

VAUGHAN, Ontario, March 01, 2024 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX: MRE), a diversified and global automotive supplier engaged in the design, development, and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems, announced the release of its 2023 Sustainability Report.

Key Points:

VAUGHAN, Ontario, March 01, 2024 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX: MRE), a diversified and global automotive supplier engaged in the design, development, and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems, announced the release of its 2023 Sustainability Report.
This report showcases Martinrea’s commitment to Environmental, Social, and Governance (ESG) by featuring sustainability achievements over the past year and our strategy for further improvement.
“By utilizing our expertise in product development and lightweighting technologies, we are committed to advancing our sustainability initiatives; helping to decrease global carbon emissions and remain ahead of market changes.”
“Our sustainability and success also comes down to culture, as emphasized in our 2023 Sustainability Report,” said Rob Wildeboer, Executive Chairman.
To view or download Martinrea’s 2023 Sustainability Report, visit: www.martinrea.com/sustainability/

Accurate Identification of Sepsis using SeptiCyte® RAPID and Comparison with other Biomarkers Presented at Society of Critical Care Medicine (SCCM) Critical Care Congress 2024

Retrieved on:

월요일, 1월 22, 2024

MHA, Patient, Systemic inflammatory response syndrome, Biomarker, MD, Society, SIRS, Critical care, Q&A, Systemic, Congress, Sepsis, Doctor of Philosophy, Critical Care Medicine (journal), SCCM

SEATTLE and BRISBANE, Australia, Jan. 22, 2024 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that data validating the use of SeptiCyte® RAPID in differentiating sepsis from systemic inflammatory response syndrome (SIRS) was selected for presentation on Sunday, January 21, during the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress in Phoenix, Arizona, January 21 to 23, 2024.

Key Points:

Immunexpress Chief Medical Officer Dr. Roy Davis presented the poster entitled, "Accurate Sepsis Identification Using SeptiCyte® RAPID & Other Biomarkers of Systemic Inflammation" in a Research Snapshot theatre and fielded questions afterward in a Q&A discussion.
"The data demonstrate that no combination of biomarkers outperformed SeptiScore alone, or models including SeptiScore, at identifying sepsis," said Dr. Roy Davis, MD, PhD, MHA, Chief Medical Officer of Immunexpress.
"This is clinically meaningful as it demonstrates that SeptiCyte RAPID can be used to help diagnose sepsis more accurately than current sepsis diagnostic tools or clinical variables.
SeptiCyte RAPID isn't intended to be used as a standalone test, but in this study adding other biomarkers to SeptiScore didn't appreciably increase the diagnostic certainty of differentiating sepsis from SIRS."

United Renewables Embraces COP28 Insights to Forge a Progressive Path in 2024

Retrieved on:

화요일, 1월 9, 2024

Isle, London Business School, Renewable energy, COP28, Policy, Finance Secretary (India), Climate change, Systemic

DOUGLAS, Isle of Man, Jan. 09, 2024 (GLOBE NEWSWIRE) -- In the wake of the influential COP28 Debrief Breakfast, United Renewables is poised to announce its ambitious plans for 2024, marking a significant step forward in the renewable energy sector. This strategic move, influenced by the outcomes of COP28, positions the company to address the challenges and seize the opportunities in a rapidly evolving energy landscape.

Key Points:

United Renewables played a pivotal role in these conversations, shaping a forward-thinking strategy that responds to the global need for sustainable energy solutions.
United Renewables' Vision for 2024:
Ramping Up Renewable Energy: Aligned with the global goal to triple renewable energy by 2030, United Renewables is expanding its portfolio of green energy projects.
Setting New Standards: As a leader in renewable energy, United Renewables is committed to raising the bar for sustainability and innovation.
United Renewables invites everyone to be part of this transformative journey towards a sustainable 2024.

The Josh Bersin Company Introduces Systemic HR™, a Global Initiative to Redefine the Role of Human Resources in Business

Retrieved on:

화요일, 12월 5, 2023

The Systemic HR Initiative, including a new study, The Definitive Guide to Human Resources: Systemic HR, from The Josh Bersin Company, is designed to help CHROs address these issues.

Key Points:

The Systemic HR Initiative, including a new study, The Definitive Guide to Human Resources: Systemic HR, from The Josh Bersin Company, is designed to help CHROs address these issues.
"We believe adoption of the Systemic HR Initiative moves HR from a service delivery function to a proactive, solution-based consulting and advisory role."
Systemic HR research deliverables include a comprehensive research study, an organizational maturity model, Systemic HR Framework, specific action steps to move to Systemic HR, and a series of in-depth case studies describing the journey towards Systemic HR.
The Josh Bersin Company will also be launching a Systemic HR Awards program, starting at the company's annual executive conference, Irresistible 2024, to celebrate companies that embrace and implement the principles and practices of Systemic HR.

PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome

Retrieved on:

목요일, 11월 23, 2023

Study reveals a promising avenue for addressing Idiopathic Systemic Capillary Leak Syndrome (ISCLS, a.k.a.

Key Points:

Study reveals a promising avenue for addressing Idiopathic Systemic Capillary Leak Syndrome (ISCLS, a.k.a.
The results underscore the novel mechanism of action, demonstrating the ability of PMC-403 to reduce vascular leakage associated with ISCLS in the preclinical models.
In February 2023, the US FDA granted Orphan Drug Designation (ODD) for PMC-403 for the treatment of Systemic Capillary Leak Syndrome.
Dr. Kirk Druey's team shared enthusiasm for the potential breakthrough, underscoring their strong determination to advance into clinical trial.

DENSO's Christina Khim Earns Runner Up at the CADIA Impact Awards in Systemic Change Category

Retrieved on:

목요일, 11월 9, 2023

CADIA, Khim, Burma Center Prague, Fixed-point iteration, Systemic, HR, DEIB, DENSO, Dignity, Workplace, Environment, Philosophy, Creative industries, Management

SOUTHFIELD, Mich., Nov. 9, 2023 /PRNewswire/ -- DENSO, a leading mobility supplier, today announced that CADIA has recognized Christina Khim as Runner Up of the 2023 CADIA Impact Awards in the category of Systemic Change, Individual. Khim is an advanced human resources (HR) business partner at DENSO's thermal manufacturing facility in Battle Creek, Michigan, who works tirelessly to bridge cultural divides and support employees of diverse backgrounds.

Key Points:

Khim honored for contributions to workplace diversity, equity and inclusion
SOUTHFIELD, Mich., Nov. 9, 2023 /PRNewswire/ -- DENSO , a leading mobility supplier, today announced that CADIA has recognized Christina Khim as Runner Up of the 2023 CADIA Impact Awards in the category of Systemic Change, Individual.
"I'm honored to be recognized at this year's CADIA Impact Awards," Khim said.
The Systemic Change category of the CADIA Impact Awards highlights individuals and teams who are determined to break down systemic bias and address organizational barriers to inclusion and equity in the workplace.
"We are pleased to celebrate Christina's ability to spark systemic change and make a positive impact," said Cheryl Thompson, founder and CEO of CADIA.